The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Race-agnostic AI models maintain accuracy in predicting M-protein levels in multiple myeloma
In this video, Ehsan Malek, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses the potential of using artificial intelligence (AI) models in multiple myeloma (MM) to predict serum M-protein levels and highlights that the addition of race data to these machine learning models does not affect their accuracy and predictive power. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
